SCHEMBL967720

SCHEMBL967720

O=C(O)c1ccccc1Cc1nnc(Cl)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
POLB P06746 1/20 0.43
FOLH1 Q04609 1/20 0.42
TP53 P04637 1/20 0.42
HTT P42858 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.42
NR4A1 P22736 1/20 0.41
ALDH1A1 P00352 5/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 2/20 0.40
CYP2C9 P11712 1/20 0.40
HIF1A Q16665 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
GAA P10253 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL969967 0.82 ALDH1A1 (0.57) TSHRFOLH1TP53ALDH1A1MAPT
SCHEMBL11010933 0.74 HDAC6 (0.57) POLBHTTMRGPRX4ALDH1A1MAPT
SCHEMBL69352 0.74 TSHR (0.68) TSHRPOLBFOLH1TP53HTT
SCHEMBL4905340 0.72 TSHR (0.72) TSHRPOLBFOLH1TP53HTT
SCHEMBL17938486 0.72 TSHR (0.66) TSHRPOLBFOLH1TP53HTT
SCHEMBL5455142 0.72 ALDH1A1 (0.61) TSHRFOLH1TP53HTTMRGPRX4
SCHEMBL9396653 0.70 TSHR (0.58) TSHRFOLH1TP53HTTMRGPRX4
SCHEMBL23003 0.69 TSHR (0.79) TSHRFOLH1ALDH1A1KMT2ACYP2C9
SCHEMBL7374000 0.69 TSHR (0.57) TSHRPOLBMRGPRX4ALDH1A1MEN1
Chlorobenzene SCHEMBL17841044 0.68 FOLH1 (0.52) TSHRFOLH1TP53HTTMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7871982-B2 Lincomycin derivatives and antimicrobial agents comprising the same as active ingredient MEIJI SEIKA KAISHA, LTD. (JP) 2011-01-18 US disclosed
US-20090156512-A1 potent activity against resistant pneumococci MEIJI SEIKA KAISHA, LTD. (JP) 2009-06-18 US disclosed
EP-1970377-A1 LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT MEIJI SEIKA KAISHA LTD. (JP) 2008-09-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156512-A1 potent activity against resistant pneumococci H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NAT1, NPM1 TSHR 1003/4885POLB 2813/4885FOLH1 4788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.